Additional mutations—particularly in genes involved in chromatin regulation such as PBRM1, SETD2, BAP1—are now recognized as critical contributors to ccRCC development and progression [99,100,101]. The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.